Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities
Net Loss	$ (2,743,015)	$ (1,179,481)
Adjustments to reconcile net loss to net cash used by operating activities:
Stock compensation	409,333	688,000
Depreciation and amortization	119,371	20,245
Loss on settlement of debt	18,281	81,887
Loss on extinguishment of debt	70,864	50,756
Gain on settlement of debt	(10,080)	0
Gain on bargain purchase	(91,870)	0
Rent accretion of right-of-use asset	2,047	0
Amortization of debt discount	212,103	6,771
Day one derivative loss	125,408	0
Change in fair value of compound embedded derivative	592,649	(17,360)
Changes in operating assets & liabilities
Prepaid expenses	(4,417)	5,758
Inventory	5,236	0
Accounts payable and accrued liabilities	90,154	(13,823)
Related party advances	29,630	0
Deferred revenue	68,539	9,879
Net cash used by operating activities	(1,105,767)	(347,368)
Cash Flows from Investing Activities
Business acquisitions	(114,110)	(55,000)
Payments to related parties	0	(174,244)
Capital expenditures	(178,028)	(78,612)
Net cash used by investing activities	(292,138)	(307,856)
Cash Flows from Financing Activities
Proceeds from notes payable	122,766	14,912
Proceeds from convertible notes payable	865,000	397,000
Repayments related to payable due for business combinations	(15,000)	0
Payment to note payable	(11,818)	(8,000)
Purchase of cancelled stock	0	(101,250)
Issuance of common stock	465,000	400,000
Net cash provided by financing activities	1,425,948	702,662
Increase in Cash	28,043	47,438
Cash at beginning of period	46,729	27,579
Cash (and equivalents) at end of period	74,772	75,017
Supplemental Cash Flow Information
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Non-cash investing and financing activities:
Conversion of note payable to equity	303,212	0
23,000,000 shares of common stock issued for business combination	0	147,200
29,454,800 shares returned in exchange for forgiveness of loan receivable	$ 0	$ 644,441